Thermogenic effect of triiodothyroacetic acid at low doses in rat adipose tissue without adverse side effects in the thyroid axis

American Journal of Physiology - Endocrinology and Metabolism

Volumn 294, Issue 4, 2008, Pages

  Medina Gomez, G ^a,c   Calvo, R M ^a   Obregon, M J ^a,b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Deiodinases; Leptin; Lipoprotein lipase; Thermogenesis

Indexed keywords

LIOTHYRONINE; LIPOPROTEIN LIPASE; THYROTROPIN; THYROXINE; TIRATRICOL; UNCOUPLING PROTEIN 2;

ADIPOSE TISSUE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVITY; FEMALE; HORMONAL REGULATION; HYPOPHYSIS THYROID SYSTEM; MUSCLE METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT; THERMOGENESIS; THYROID FUNCTION;

ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ANIMALS; BODY TEMPERATURE REGULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENERGY METABOLISM; FEMALE; GENE EXPRESSION; IODIDE PEROXIDASE; ION CHANNELS; LEPTIN; MITOCHONDRIAL PROTEINS; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; THYROID GLAND; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 41649091609     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00417.2007     Document Type: Article

References (62)

1. Amma LL, Campos-Barros A, Wang Z, Vennstrom B, Forrest D. Distinct tissue-specific roles for thyroid hormone receptors beta and alpha1 in regulation of type 1 deiodinase expression. Mol Endocrinol 15: 467-475, 2001.
2. Beck-Peccoz P, Piscitelli G, Cattaneo MG, Faglia G. Successful treatment of hyperthyroidism due to nonneoplastic pituitary TSH hypersecretion with 3,5,3′-triiodothyroacetic acid (TRIAC). J Endocrinol Invest 6:217-223, 1983.
3. Beck-Peccoz P, Sartorio A, De Medici C, Grugni G, Morabito F, Faglia G. Dissociated thyromimetic effects of 3,5,3′-triiodothyroacetic acid (TRIAC) at the pituitary and peripheral tissue levels. J Endocrinol Invest 11: 113-118, 1988.
4. Bianco AC, Kieffer JD, Silva JE. Adenosine 3′,5′- monophosphate and thyroid hormone control of uncoupling protein messenger ribonucleic acid in freshly dispersed brown adipocytes. Endocrinology 130: 2625-2633, 1992.
5. Bianco AC, Sheng X, Silva JE. Triiodothyronine amplifies norepinephrine stimulation of uncoupling protein gene transcription by a mechanism not requiring protein synthesis. J Biol Chem 263: 18168-18175, 1988.
6. Bianco AC, Silva JE. Intracellular conversion of thyroxine to triiodothyronine is required for the optimal thermogenic function of brown adipose tissue. J Clin Invest 79: 295-300, 1987.
7. Blanchette-Mackie EJ, Masuno H, Dwyer NK, Olivecrona T, Scow RO. Lipoprotein lipase in myocytes and capillary endothelium of heart: immunocytochemical study. Am J Physiol Endocrinol Metab 256: E818-E828, 1989.
8. Bouillaud F, Weissenbach J, Ricquier D. Complete cDNA-derived amino acid sequence of rat brown fat uncoupling protein. J Biol Chem 261: 1487-1490, 1986.
9. Bracco D, Morin O, Schutz Y, Liang H, Jequier E, Burger AG. Comparison of the metabolic and endocrine effects of 3,5,3′- triiodothyroacetic acid and thyroxine. J Clin Endocrinol Metab 77: 221-228, 1993.
10. Carneheim C, Nedergaard J, Cannon B. Beta-adrenergic stimulation of lipoprotein lipase in rat brown adipose tissue during acclimation to cold. Am J Physiol Endocrinol Metab 246: E327-E333, 1984.
11. Commins SP, Watson PM, Padgett MA, Dudley A, Argyropoulos G, Gettys TW. Induction of uncoupling protein expression in brown and white adipose tissue by leptin. Endocrinology 140: 292-300, 1999.
12. Cummings DE, Brandon EP, Planas JV, Motamed K, Idzerda RL, McKnight GS. Genetically lean mice result from targeted disruption of the RII beta subunit of protein kinase A. Nature 382: 622-626, 1996.
13. Dumas P, Autissier N, Loireau A, Michel R. [Effects of 3,5,3′-triiodothyroacetic acid (TRIAC) on protein metabolism of genetically obese or non-obese Zucker rats]. C R Seances Soc Biol Fil 176: 178-183, 1982.
14. Escobar-Morreale HF, Obregon MJ, Escobar del Rey F, Morreale de Escobar G. Tissue-specific patterns of changes in 3,5,3′-triiodo- L-thyronine concentrations in thyroidectomized rats infused with increasing doses of the hormone. Which are the regulatory mechanisms? Biochimie 81: 453-462, 1999.
15. Escobar-Morreale HF, Obregon MJ, Hernandez A, Escobar del Rey F, Morreale de Escobar G. Regulation of iodothyronine deiodinase activity as studied in thyroidectomized rats infused with thyroxine or triiodothyronine. Endocrinology 138: 2559-2568, 1997.
16. Everts ME, Visser TJ, Moerings EP, Docter R, van Toor H, Tempelaars AM, de Jong M, Krenning EP, Hennemann G. Uptake of triiodothyroacetic acid and its effect on thyrotropin secretion in cultured anterior pituitary cells. Endocrinology 135: 2700-2707, 1994.
17. Gavin LA, Livermore BM, Cavalieri RR, Hammond ME, Castle JN. Serum concentration, metabolic clearance, and production rates of 3,5,3′-triiodothyroacetic acid in normal and athyreotic man. J Clin Endocrinol Metab 51: 529-534, 1980.
18. Goslings B, Schwartz HL, Dillmann W, Surks MI, Oppenheimer JH. Comparison of the metabolism and distribution of L-triiodothyronine and triiodothyroacetic acid in the rat: a possible explanation of differential hormonal potency. Endocrinology 98: 666-675, 1976.
19. Guerra C, Koza RA, Yamashita H, Walsh K, Kozak LP. Emergence of brown adipocytes in white fat in mice is under genetic control. Effects on body weight and adiposity. J Clin Invest 102: 412-420, 1998.
20. Hernandez A, Obregon MJ. Presence and mRNA expression of thyroid receptors in differentiating rat brown adipocytes. Mol Cell Endocrinol 121: 37-46, 1996.
21. 3 stimulates resting metabolism and UCP-2 and UCP-3 mRNA but not nonphosphorylating mitochondrial respiration in mice. Am J Physiol Endocrinol Metab 277: E380-E389, 1999.
22. Juge-Aubry CE, Morin O, Pernin AT, Liang H, Philippe J, Burger AG. Long-lasting effects of Triac and thyroxine on the control of thyrotropin and hepatic deiodinase type I. Eur J Endocrinol 132: 751-758, 1995.
23. Kunitake JM, Hartman N, Henson LC, Lieberman J, Williams DE, Wong M, Hershman JM. 3,5,3′-Triiodothyroacetic acid therapy for thyroid hormone resistance. J Clin Endocrinol Metab 69: 461-466, 1989.
24. Lanni A, De Felice M, Lombardi A, Moreno M, Fleury C, Ricquier D, Goglia F. Induction of UCP2 mRNA by thyroid hormones in rat heart. FEBS Lett 418: 171-174, 1997.
25. Leonardsson G, Steel JH, Christian M, Pocock V, Milligan S, Bell J, So PW, Medina-Gomez G, Vidal-Puig A, White R, Parker MG. Nuclear receptor corepressor RIP140 regulates fat accumulation. Proc Natl Acad Sci USA 101: 8437-8442, 2004.
26. Liang H, Juge-Aubry CE, O'Connell M, Burger AG. Organ-specific effects of 3,5,3′-triiodothyroacetic acid in rats. Eur J Endocrinol 137: 537-544, 1997.
27. Lind P, Langsteger W, Koltringer P, Eber O. 3,5,3′- triiodothyroacetic acid (TRIAC) effects on pituitary thyroid regulation and on peripheral tissue parameters. Nuklearmedizin 28: 217-220, 1989.
28. Loncar D. Convertible adipose tissue in mice. Cell Tissue Res 266: 149-161, 1991.
29. LoPresti JS, Dlott RS, Nicoloff RS, Nicoloff JT. "In vivo" induction of Triac (T3AC) formation in fasting man. Clin Res 41: 83A, 1993.
30. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
31. Martinez-de Mena R, Hernandez A, Obregon MJ. Triiodothyronine is required for the stimulation of type II 5′-deiodinase mRNA in rat brown adipocytes. Am J Physiol Endocrinol Metab 282: E1119-E1127, 2002.
32. Masaki T, Yoshimatsu H, Kakuma T, Hidaka S, Kurokawa M, Sakata T. Enhanced expression of uncoupling protein 2 gene in rat white adipose tissue and skeletal muscle following chronic treatment with thyroid hormone. FEBS Lett 418: 323-326, 1997.
33. 3 and Triac inhibit leptin secretion and expression in brown and white rat adipocytes. Biochim Biophys Acta 1682: 38-47, 2004.
34. Medina-Gomez G, Hernandez A, Calvo RM, Martin E, Obregon MJ. Potent thermogenic action of triiodothyroacetic acid in brown adipocytes. Cell Mol Life Sci 60: 1957-1967, 2003.
35. Menegay C, Juge C, Burger AG. Pharmacokinetics of 3,5,3′-triiodothyroacetic acid and its effects on serum TSH levels. Acta Endocrinol 121: 651-658, 1989.
36. Moreno M, Kaptein E, Goglia F, Visser TJ. Rapid glucuronidation of tri- and tetraiodothyroacetic acid to ester glucuronides in human liver and to ether glucuronides in rat liver. Endocrinology 135: 1004-1009, 1994.
37. Morreale de Escobar G, Pastor R, Obregón MJ, Escobar del Rey F. Effects of maternal hypothyroidism on the weight and thyroid hormone content of rat embryonic tissues. Endocrinology 117: 1890-1900, 1985.
38. Nakamura Y, Chopra IJ, Solomon DH. An assessment of the concentration of acetic acid and propionic acid derivatives of 3,5,3′-triiodothyronine in human serum. J Clin Endocrinol Metab 46: 91-97, 1978.
39. Nicholls D, Cunningham SA, Rial E. The bioenergetic mechanisms of brown adipose tissue mitochondria. In: Brown Adipose Tissue, edited by Trayhurn P and Nicholls DG. London: Edward Arnold, 1986, p. 52-85.
40. O'Brien KD, Ferguson M, Gordon D, Deeb SS, Chait A. Lipoprotein lipase is produced by cardiac myocytes rather than interstitial cells in human myocardium. Arterioscler Thromb 14: 1445-1451, 1994.
41. Obregon MJ, Calvo R, Hernandez A, Escobar del Rey F, Morreale de Escobar G. Regulation of uncoupling protein (UCP) mRNA and 5′Deiodinase (5′D) activity by thyroid hormones in fetal brown adipose tissue. Endocrinology 137: 4721-4729, 1996.
42. Obregon MJ, Pascual A, de Escobar GM, Escobar del Rey F. Pituitary and plasma thyrotropin, thyroxine, and triiodothyronine after hyperthyroidism. Endocrinology 104: 1467-1473, 1979.
43. Obregon MJ, Pitamber R, Jacobsson A, Nedergaard J, Cannon B. Euthyroid status is essential for the perinatal increase in thermogenin mRNA in brown adipose tissue of rat pups. Biochem Biophys Res Commun 148: 9-14, 1987.
44. Obregon MJ, Ruiz de Oña C, Hernandez A, Calvo RM, Escobar del Rey F, Morreale de Escobar G. Thyroid hormones and 5′-deiodinase in rat brown adipose tissue during fetal life. Am J Physiol Endocrinol Metab 257: E625-E631, 1989.
45. Oliver P, Pico C, Martinez N, Bonet ML, Palou A. In vivo effects of CGP-12177 on the expression of leptin and uncoupling protein genes in mouse brown and white adipose tissues. Int J Obes Relat Metab Disord 24: 423-428, 2000.
46. Pachucki J, Burmeister LA, Larsen PR. Thyroid hormone regulates hyperpolarization-activated cyclic nucleotide-gated channel (HCN2) mRNA in the rat heart. Circ Res 85: 498-503, 1999.
47. Pittman JA, Brown RW, Beschi RJ, Smitherman TC. Selectivity of action of 3,3′,5′-triiodothyronine. Endocrinology 86: 1451-1454, 1970.
48. Rehnmark S, Bianco AC, Kieffer JD, Silva JE. Transcriptional and posttranscriptional mechanisms in uncoupling protein mRNA response to cold. Am J Physiol Endocrinol Metab 262: E58-E67, 1992.
49. Ribeiro MO, Carvalho SD, Schultz JJ, Chiellini G, Scanlan TS, Bianco AC, Brent GA. Thyroid hormone-sympathetic interaction and adaptive thermogenesis are thyroid hormone receptor isoform-specific. J Clin Invest 108: 97-105, 2001.
50. Ruiz de Ona C, Morreale de Escobar G, Calvo R, Escobar del Rey F, Obregon MJ. Thyroid hormones and 5 -deiodinase in the rat fetus late in gestation: effects of maternal hypothyroidism. Endocrinology 128: 422-432, 1991.
51. Rutgers M, Heusdens FA, Bonthuis F, Visser TJ. Metabolism of triiodothyroacetic acid (TA3) in rat liver. II. Deiodination and conjugation of TA3 by rat hepatocytes and in rats in vivo. Endocrinology 125: 433-443, 1989.
52. 3. Mol Endocrinol 4: 227-234, 1990.
53. Sherman SI, Ladenson PW. Organ-specific effects of tiratricol: a thyroid hormone analog with hepatic, not pituitary, superagonist effects. J Clin Endocrinol Metab 75: 901-905, 1992.
54. Sherman SI, Ringel MD, Smith MJ, Kopelen HA, Zoghbi WA, Ladenson PW. Augmented hepatic and skeletal thyromimetic effects of tiratricol in comparison with levothyroxine. J Clin Endocrinol Metab 82: 2153-2158, 1997.
55. Siegrist-Kaiser C, Burger AG. Modification of the side chain of thyroid hormones. In: Thyroid Hormone Metabolism, edited by Wu SY and Visser TJ. Boca Raton: CRC, 1994, p. 175-198.
56. Silva JE, Larsen PR. Adrenergic activation of triiodothyronine production in brown adipose tissue. Nature 305: 712-713, 1983.
57. Silva JE, Larsen PR. Potential of brown adipose tissue type II thyroxine 5′-deiodinase as a local systemic source of triiodothyronine in rats. J Clin Invest 76: 2296-2305, 1985.
58. Silva JE, Rabelo R. Regulation of the uncoupling protein gene expression. Eur J Endocrinol 136: 251-264, 1997.
59. Snedecor GW, Cochran WG. Statistical Methods. Ames, Iowa: Iowa State University Press, 1980.
60. Torre P, Bertoli M, Di Giovanni S, Scommegna S, Conte C, Novelli G, Cianfarani S. Endocrine and neuropsychological assessment in a child with a novel mutation of thyroid hormone receptor: response to 12-month triiodothyroacetic acid (TRIAC) therapy. J Endocrinol Invest 28: 657-662, 2005.
61. Trayhurn P. Brown adipose tissue and energy balance. In: Brown Adipose Tissue, edited by Trayhurn P and Nicholls DG. London: Edward Arnold, 1986, p. 299-338.
62. Trost SU, Swanson E, Gloss B, Wang-Iverson DB, Zhang H, Volodarsky T, Grover GJ, Baxter JD, Chiellini G, Scanlan TS, Dillmann WH. The thyroid hormone receptor-beta-selective agonist GC-1 differentially affects plasma lipids and cardiac activity. Endocrinology 141: 3057-3064, 2000.